Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2007

View Archived Issues

Alefacept active, well tolerated in atopic dermatitis

Good nail penetration results for onychomycosis treatments IVR-101 and IVR-102

Pentavalent human-bovine rotavirus vaccine effective at end of shelf life

Recent Corus patent imparts novel therapeutic agents for chronic obstructive pulmonary disease

New treatments for gastrointestinal disorders claimed in recent patent literature

Novel treatments for musculoskeletal and connective tissue disorders claimed in recent patents

UCB and ImClone terminate CDP-791 agreement

Novel antiviral agents disclosed in recent patent from University of California, Oakland

Novel vanadium complex shows insulin mimetic properties in vivo

Bicyclic monoterpene diol mixture may be useful to repair photodamaged skin

VLA-2: a potential target for the treatment of multiple sclerosis

Jerini and Baxter expand hemophilia research collaboration

Seliciclib to be investigated for nasopharyngeal cancer

Snapshots on preclinical data reported at the 32nd Annual Stroke Conference

Chinese clinical trials confirm XiMingTing's utility in menopausal symptoms

Sciele Pharma licenses fenofibrate/pravastatin combination for mixed dyslipidemia

Migenix updates status of Schering-Plough's license option

Phase II trial of phosphate binder ILY-101 completes enrollment

Avigen reports findings of safety study of AV-411 for neuropathic pain

ATX-MS1467 vaccine cleared for U.K. phase I study in MS

SP-6300 shows potential for Cushing's syndrome

Kallikrein 6 studied as a prognostic marker and a therapeutic target in ovarian cancer

Japanese study supports further evaluation of hypertension chemotherapy

FDA awards orphan drug status to maribavir for CMV viremia and disease

Zingo NDA accepted for filing

Neuroprotective effects of Necrostatin-1 in mice models of ischemic stroke

Sutent approved with new data for advanced renal cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.